» Articles » PMID: 38352796

Exploring Demographical, Clinical, and Dietary Determinants of Vitamin D Deficiency Among Adults in Douala, Cameroon During the COVID-19 Era

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Feb 14
PMID 38352796
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Vitamin D deficiency (VDD) is a global public health problem in African populations. This study aimed at determining the prevalence, characteristics, and determinants of VDD in the era of SARS-CoV-2/COVID-19. This study was conducted from January to September 2022 in seven health facilities in Douala, Cameroon.

Methods: A structured, pre-tested questionnaire was administered to each participant to collect participants' information. Molecular detection of the SARS-CoV-2 genome was done. A serum level of 25-hydroxyvitamin D < 20 ng/mL was used to diagnose VDD.

Results: A total of 420 participants were included in the study. A Serum levels of 25(OH) vitamin D were reduced in SARS-CoV-2 (+) patients as compared to SARS-CoV-2 (-) patients (21.69 ± 5.64 ng/mL 42.09 ± 20.03 ng/mL,  < 0.0001). The overall prevalence of VDD was 10.2 %. SARS-CoV-2 (+) individuals had nearly two times more risk of being VDD compared to SARS-CoV-2 (-) individuals (aRR = 1.81,  < 0.0001). The risk of VDD was reduced by 46 % and 71 % in those consuming cocoa bean or powder regularly (aRR = 0.54,  = 0.03) and rarely (aRR = 0.29,  = 0.02) as compared to those never consuming it. Likewise, the risk of VDD was reduced by 59 % and 78 % in those consuming sardine fish regularly (aRR = 0.47,  = 0.002) and rarely (aRR = 0.22,  = 0.03). Overall, the association between VDD and SARS-CoV-2 infection was consistent, i.e., reduced risk of VDD in SARS-CoV-2 (-) individuals, after stratification for confounding variables.

Conclusion: This study outlined a high burden of VDD, a strong link between VDD and SARS-CoV-2, and suggests the possible utility of vitamin D supplementation for COVID-19 patients in Cameroon.

References
1.
Hadizadeh F . Supplementation with vitamin D in the COVID-19 pandemic?. Nutr Rev. 2020; 79(2):200-208. PMC: 7454793. DOI: 10.1093/nutrit/nuaa081. View

2.
Moguem Soubgui A, Foko L, Embolo Enyegue E, Ndeme Mboussi W, Mbebi Enone J, Ntatou Lemouchele I . Confounding role of comorbidities and COVID-19 vaccination uptake in clinical utility of hematological biomarkers in Cameroonian patients infected with SARS-CoV-2. IJID Reg. 2023; 8:129-136. PMC: 10472227. DOI: 10.1016/j.ijregi.2023.08.003. View

3.
Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A . Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020; 74(11):1498-1513. PMC: 7091696. DOI: 10.1038/s41430-020-0558-y. View

4.
Bikle D . Vitamin D regulation of immune function during covid-19. Rev Endocr Metab Disord. 2022; 23(2):279-285. PMC: 8799423. DOI: 10.1007/s11154-021-09707-4. View

5.
Teshome A, Adane A, Girma B, Mekonnen Z . The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis. Front Public Health. 2021; 9:624559. PMC: 7973108. DOI: 10.3389/fpubh.2021.624559. View